Pentagon temporarily rescinds mandatory testosterone screening guidance for troops aged 30 and older
The Pentagon temporarily rescinded its newly published clinical guidance for a mandatory testosterone-deficiency screening policy for U.S. service members aged 30 and older, a U.S. official confirmed on Thursday. The guidance, posted on September 2, 2026, was removed the next day for updates, with interim guidance remaining in effect. The policy aimed to improve readiness by screening men and women for hormonal issues during annual health assessments.
Editorial responsibility
- No named human review is recorded for this page.
- Reports are grouped by semantic similarity and deterministic rules. Language models may assist titles, summaries, translation and cross-source analysis; the page itself is projected from evidence records.
- Current automated evidence projection
Cross-source coverage
Wire timeline
Pentagon temporarily rescinds guidance on mandatory testosterone screening for troops
The Pentagon has temporarily rescinded newly published clinical guidance for a mandatory testosterone-deficiency screening policy for U.S. service members aged 30 and older, a U.S. official told Reuters on Thursday, September 3, 2026. The guidance, titled 'Clinical Guidance for Health and Human Performance Optimization,' was posted on the Pentagon's website on Wednesday but was removed by Thursday, along with an accompanying statement from spokesperson Sean Parnell. The official stated the draft document, published on September 2, has been temporarily rescinded for updates, while interim guidance remains in effect. The detailed guidelines had outlined separate screening paths for men and women during annual health assessments, with men aged 30 and older facing a questionnaire that could lead to a blood test and potential testosterone therapy. Women would also be screened via questionnaire, with treatment options for hormonal imbalances, including testosterone for Hypoactive Sexual Desire Disorder. The policy was intended to improve military readiness by addressing hormonal and energy-availability issues.
Pentagon temporarily rescinds clinical guidance on mandatory testosterone screening for troops
The Pentagon has temporarily rescinded newly published clinical guidance for a mandatory testosterone-deficiency screening policy for U.S. service members aged 30 and older, a U.S. official confirmed to Reuters on Thursday. The guidance, titled 'Clinical Guidance for Health and Human Performance Optimization,' was posted on the Pentagon's website on Wednesday but was removed by Thursday, along with an accompanying statement from spokesperson Sean Parnell. The official stated the draft document was rescinded to allow for updates, while interim guidance remains in effect. The policy aimed to improve military readiness by identifying and managing hormonal and energy-availability issues. It outlined separate screening paths for men and women during annual health assessments. Men aged 30 and older would have been screened via a questionnaire that could lead to a blood test for testosterone levels and potential hormone therapy. Women would also be screened via a questionnaire, with treatment options for hormonal imbalances, including testosterone use for conditions like Hypoactive Sexual Desire Disorder. Links to the memo and statement now show 'Page Not Found' on Pentagon and Defense Health Agency websites.
Pentagon temporarily rescinds guidance on mandatory testosterone screening for troops
The Pentagon has temporarily rescinded recently published clinical guidance for a new mandatory testosterone-deficiency screening policy for U.S. service members aged 30 and older, according to a U.S. official who spoke to Reuters on Thursday, September 3, 2026. The guidance, titled 'Clinical Guidance for Health and Human Performance Optimization,' was posted on the Pentagon's website on Wednesday but was removed by Thursday, along with an accompanying statement from spokesperson Sean Parnell. The official stated that the draft document published on September 2 has been temporarily rescinded to allow for updates, while interim guidance remains in effect. The detailed guidelines had outlined separate screening paths for men and women during annual health assessments, with men aged 30 and older facing a questionnaire that could trigger a blood test and potential testosterone therapy. Women would also be screened via questionnaire, with treatment options for hormonal imbalances including testosterone for conditions like Hypoactive Sexual Desire Disorder. The policy was intended to improve military readiness by identifying hormonal and energy-availability issues.
Show 2 older updatesHide older updates
Pentagon temporarily rescinds guidance on mandatory testosterone screening for troops
The Pentagon has temporarily rescinded recently published clinical guidance for a new mandatory testosterone-deficiency screening policy for U.S. service members aged 30 and older, according to a U.S. official who spoke to Reuters on Thursday. The guidance, titled 'Clinical Guidance for Health and Human Performance Optimization,' was posted on the Pentagon's website on Wednesday but was removed by Thursday, along with an accompanying statement from spokesperson Sean Parnell. A Pentagon official stated that the draft document, published on September 2, 2026, has been temporarily rescinded to allow for updates, while interim guidance remains in effect. The detailed guidelines had outlined separate screening paths for men and women during annual health assessments, with men aged 30 and older facing a questionnaire that could lead to blood tests and potential testosterone therapy. Women would also be screened via questionnaire, with treatment options for hormonal imbalances, including testosterone for Hypoactive Sexual Desire Disorder. The policy was intended to improve military readiness by identifying and managing hormonal and energy-availability issues.
Pentagon temporarily rescinds guidance on mandatory testosterone screening for troops
The Pentagon has temporarily rescinded recently published clinical guidance for a new mandatory testosterone-deficiency screening policy for U.S. service members aged 30 and older, a U.S. official told Reuters on Thursday. The guidance, titled 'Clinical Guidance for Health and Human Performance Optimization,' was posted on the Pentagon's website on Wednesday but was removed by Thursday, along with an accompanying statement from spokesperson Sean Parnell. A Pentagon official stated that the draft document published on September 2, 2026, has been temporarily rescinded to allow for updates, with interim guidance remaining in effect. The detailed guidelines had outlined separate screening paths for men and women during annual health assessments, aimed at improving military readiness by identifying and managing hormonal and energy-availability issues. Men aged 30 and older would have been screened via a questionnaire that could trigger a blood test and potential testosterone therapy. Women would also be screened via a questionnaire, with treatment options for hormonal imbalance conditions, including testosterone use for Hypoactive Sexual Desire Disorder. Links to the memo and statement now show 'Page Not Found' on Pentagon and Defense Health Agency websites.